Phase II clinical trial to evaluate the safety and efficacy of particle radiotherapy preceded atezolizumab plus bevacizumab treatment in patients with unresectable multiple hepatocellular carcinoma - Trial UMIN000048296
Access comprehensive clinical trial information for UMIN000048296 through Pure Global AI's free database. This phase not specified trial is sponsored by Kobe University and is currently Recruiting. The study focuses on Hepatocellular carcinoma.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to University Hospital Medical Information Network data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Free Database
Powered by Pure Global AI
840K+ Trials
UMIN000048296
Recruiting
drug
Trial Details
University Hospital Medical Information Network • UMIN000048296
Phase II clinical trial to evaluate the safety and efficacy of particle radiotherapy preceded atezolizumab plus bevacizumab treatment in patients with unresectable multiple hepatocellular carcinoma
Study Focus
Sponsor & Location
Kobe University
Japan
Timeline & Enrollment
N/A
Apr 01, 2023
N/A
ICD-10 Classifications
Malignant neoplasm: Hepatoblastoma
Malignant neoplasm: Liver cell carcinoma
Malignant neoplasm: Other specified carcinomas of liver
Malignant neoplasm: Liver, unspecified
Malignant neoplasm: Hepatic flexure
Data Source
University Hospital Medical Information Network
UMIN000048296
Non-Device Trial